ADVERTISEMENT
2 /3 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Finance

Solugen raises $32 million for biobased H2O2

by Marc S. Reisch
May 25, 2019 | APPEARED IN VOLUME 97, ISSUE 21

 

Biobased–hydrogen peroxide maker Solugen has raised $32 million in series B funding. Just 7 months ago, it raised $14 million from investors in a series A round. One of C&EN’s 10 Start-Ups to Watch in 2018, the firm converts glucose into H2O2 and gluconic acid using a proprietary enzyme and reactor design. Solugen says it will use the new funding to scale up other products, including a mobile manufacturing platform, and to hire more chemists and marketing executives.

X

Article:

This article has been sent to the following recipient:

Leave A Comment

*Required to comment